Mackay Shields’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Mackay Shields's GILD Position: Q2 2022 in Review
Mackay Shields sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 181,555 shares — an estimated $10.8M sold.
Mackay Shields first reported a position in GILD in Q1 2018 and held it in 17 quarters. The position peaked at $65.9M in Q3 2018. 1,605 funds tracked by Wall St. Rank hold GILD as of Q2 2022.
- Mackay Shields reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
- Mackay Shields sold 181,555 Gilead Sciences shares in Q2 2022, an estimated $10.8M.
- Mackay Shields first reported a position in Gilead Sciences in Q1 2018 and held it in 17 quarters.
- Mackay Shields's Gilead Sciences position peaked at $65.9M in Q3 2018.
- 1,605 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.
Based on Mackay Shields's 13F filing for Q2 2022, filed 3 Aug 2022.